- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
46 Multiple Sclerosis Trials near New York, NY
Power is an online platform that helps thousands of Multiple Sclerosis patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerPalliative Care Information for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
50 Participants Needed
Remibrutinib vs Teriflunomide for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
800 Participants Needed
Ozanimod for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
250 Participants Needed
Tolebrutinib for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
2500 Participants Needed
High-Dose Ocrelizumab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
769 Participants Needed
Ocrelizumab vs Fingolimod for Pediatric Multiple Sclerosis
Trial Details
Key Eligibility Criteria
171 Participants Needed
Ocrelizumab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
123 Participants Needed
Foralumab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
54 Participants Needed
ATP128 + VSV-GP128 + BI 754091 for Colorectal Cancer
Trial Details
Key Eligibility Criteria
96 Participants Needed
MIND Diet for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
100 Participants Needed
Physical Therapy for Advanced Multiple Sclerosis
Trial Details
Key Eligibility Criteria
15 Participants Needed
Task-Specific Exercise for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
30 Participants Needed
Early Aggressive vs Traditional Therapy for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
900 Participants Needed
Vagal Nerve Stimulation for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
30 Participants Needed
Probiotic Chocolate for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
92 Participants Needed
Trial Details
Key Eligibility Criteria
170 Participants Needed
CC-97540 for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
120 Participants Needed
Nivolumab for Cancer
Trial Details
Key Eligibility Criteria
300 Participants Needed
Frexalimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
858 Participants Needed
Stem Cell Transplant vs Best Available Therapy for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
156 Participants Needed
Why Other Patients Applied
"I've been battling multiple sclerosis for 28 years. I've tried three medications. I keep my dosing stable, but I'm just tired of managing. I want to take control of my situation."
"I've been taking Kesimpta for a couple years now and seem to be having more flare ups. I'm only 43. I have 5 kids and feel like I'm missing my life. Sleeping my life away. I'm ready to try ANYTHING for a chance at living life again."
"I've tried 2 MS drugs but I am getting worse. I am having trouble walking long distances or for more than 30 minutes. I need to find a new medication. My doctor and I discussed some of the options in trials and I'm ready to dive in to learn more."
"I have been losing mobility in the past 3 years very rapidly. I have tried physical therapy, but it didn't really show results. I'll admit that I am not very self-motivated, so I can use some structure. I use to be extremely active and now I am like a wet rag. So I am hoping that participating in a research trial will be of help to me."
"I've been using natural supplements and would like to find something more effective. My former PCP was hesitant to prescribe modafanil. I'm interested in learning about all options available to me—including the drugs currently under research investigation."
Fenebrutinib for Relapsing Multiple Sclerosis
Trial Details
Key Eligibility Criteria
746 Participants Needed
Tolebrutinib for Primary Progressive Multiple Sclerosis
Trial Details
Key Eligibility Criteria
767 Participants Needed
Ofatumumab for Early Relapsing-Remitting Multiple Sclerosis
Trial Details
Key Eligibility Criteria
180 Participants Needed
BIIB091 for Relapsing Multiple Sclerosis
Trial Details
Key Eligibility Criteria
275 Participants Needed
Vancomycin for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
12 Participants Needed
Ofatumumab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
180 Participants Needed
Ublituximab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
600 Participants Needed
Ublituximab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
1100 Participants Needed
PIPE-307 for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
168 Participants Needed
Obexelimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
93 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Multiple Sclerosis clinical trials in New York, NY pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Multiple Sclerosis clinical trials in New York, NY work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Multiple Sclerosis trials in New York, NY 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in New York, NY for Multiple Sclerosis is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in New York, NY several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Multiple Sclerosis medical study in New York, NY?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Multiple Sclerosis clinical trials in New York, NY?
Most recently, we added Transcranial Direct Current Stimulation for Depression in Multiple Sclerosis, MIND Diet for Multiple Sclerosis and Ofatumumab for Multiple Sclerosis to the Power online platform.
What do the "Power Preferred" and "SuperSite" badges mean?
We recognize research clinics with these awards when they are especially responsive to patients who apply through the Power online platform. SuperSite clinics are research sites recognized for a high standard of rapid and thorough follow-up with patient applicants. Meanwhile, Power Preferred clinics are the top 20 across the entire Power platform, recognized for their absolute top patient experience.
Which clinics have received Power Preferred and SuperSite awards recruiting for Multiple Sclerosis trials in New York, NY?
The Multiple Sclerosis clinics in New York, NY currently recognized as SuperSites are: Columbia University Irving Medical Center in New York, New York Rutgers University - Robert Wood Johnson Medical School Site Number : 8400067 in New Brunswick, New Jersey Rutgers University - Robert Wood Johnson Medical School Site Number : 8401067 in New Brunswick, New Jersey